Global Nerve Repair Biomaterials Market Analysis and Forecasts New Research Report From 2017 To 2024

Global Nerve Repair Biomaterials Market is expected to reach USD 775.59 million by 2024 from USD 326.71 million in 2016, at a CAGR of 11.5% in the forecast period 2017 to 2024. The new market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Ask for a Sample: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-nerve-repair-biomaterials-market#utm_source=Openpr&utm_campaign=Shubham

Global Nerve Repair Biomaterials Market – Segmentation:

By Product Type [Nerve Repair {Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)}, Nerve Protection {Nerve Protectors, Nerve Wrap}], Injury Type {Epineural Nerve Repair, Perineural Nerve Repair, Group Fascicular Repair}, End User (Hospital, Clinics, Ambulatory Trauma Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World)

Browse Detailed Analysis of the Market @ http://databridgemarketresearch.com/reports/global-nerve-repair-biomaterials-market/#utm_source=Openpr&utm_campaign=Shubham

Global Nerve Repair Biomaterials Market – Drivers:

Some of the major factors driving the market for nerve repair biomaterials marketis witnessing a rapid growth due to increasing geriatric population, high incidence of nerve injuries and neurological disorders, technological advancements, expanding target application of neuromodulation devices,favourable reimbursement policies, and increased government funding.

INCREASING GERIATRIC POPULATION AND INCIDENCES OF PERIPHERAL NERVE INJURIES

Rapidly increasing geriatric population and incidence of peripheral nerve injuries and neurological disorders is a major factor contributing to the growth of this market. Painful peripheral neuropathy is a common neurological disorder which is categorised by weakness, numbness, tingling and pain, and it often starts in the hands or feet. There are more than 100 types of peripheral neuropathy with specific symptoms and prognosis.

TECHNOLOGICAL ADVANCEMENTS OVER SURGERY THROUGH AUTOGRAFTS

Nerve repairs have received the lowest priority since tissue viability is considered first and foremost on the surgeon’s mind. Vascular repair, organ integrity and bone repair care is taken immediately and nerve repairs are either not handled or are cared last. This is due to the dilemma associated with some of the peripheral nerve repair options such as autograft which leads to other morbidity. Due to these factors companies are focusing on developing new technologies.

EXPANDED TARGET APPLICATION OF NEUROMODULATION DEVICES

Application of neuromodulation to new therapeutic areas will drive growth in the market. Expansion of indications has been a historic growth driver of neuromodulation and is expected to continue to drive this market over the forecast period.
FAVOURABLE REIMBURSEMENT POLICIES

Favourable reimbursement policies and strengthening healthcare infrastructure in developing countries are factors that could propel growth of this market. Innovation in nerve regeneration techniques and improved therapies for the treatment of neurological disorders are expected to push nerve repair market towards significant growth.

Global Nerve Repair Biomaterials Market – Major Players:

Some of the other major players operating in the global nerve repair biomaterials market are:
• Integra LifeSciences Corporation,
• Stryker,
• Collagen Matrix, Inc.,
• xoGen, Inc., Checkpoint Surgical, Inc.,
• Polyganics,
• Synovis Micro Companies Alliance, Inc.

Ask For TOC: http://databridgemarketresearch.com/toc/?dbmr=global-nerve-repair-biomaterials-market#utm_source=Openpr&utm_campaign=Shubham

Nerve Repair Biomaterials Market Key Points:

Integra Life Sciences is going to dominate the injectable drug delivery market followed by Stryker Corporation and Collagen Matrix, Inc. along with others such asAxoGen, Inc., Checkpoint Surgical, Inc., Polyganics, and Synovis Micro Companies Alliance, Inc.
• Nerve Protection market is growing with the highest CAGR.
• Globally nerve grafts is driving the market with highest market share. However, a nerve conduit is growing with the highest CAGR.
• Epineural nerve repair is dominating the injury nerve repair biomaterials market.

Inquiry Before Buying: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nerve-repair-biomaterials-market#utm_source=Openpr&utm_campaign=Shubham

Table of Content:
1. INTRODUCTION
1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES
4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR
4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES
4.3.1.4. EXPANDED TARGET APPLICATIONS
4.3.2. RESTRAINTS
4.3.2.1. LACK OF PATIENT AWARENESS
4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS
4.3.3. OPPURTUNITIES
4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY
4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS
4.3.4. THREATS
4.3.4.1. DONOR SITE MORBIDITY
4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. NERVE REPAIR
6.2.1. NERVE CONDUITS
6.2.2. NERVE GRAFTS
6.2.2.1. ALLOGRAFTS
6.2.2.2. ACELLULARIZED ALLOGRAFTS
6.3. NERVE PROTECTION
6.3.1. NERVE PROTECTOR
6.3.2. NERVE WRAP
7. NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE
7.1. OVERVIEW
7.2. EPINEURAL NERVE REPAIR
7.3. PERINEURAL NERVE REPAIR
7.4. GROUP FASCICULAR NERVE REPAIR
8. NERVE REPAIR BIOMATERIALS MARKET, BY END USER
8.1. OVERVIEW
8.2. HOSPITALS
8.3. AMBULATORY TRAUMA CENTERS
8.4. CLINICS
9. NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES
11.1. AXOGEN, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT ANALYSIS
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPEMENTS
11.1.6. DATA BRIDGE ANALYSIS
11.2. CHECKPOINT SURGICAL, INC.
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT ANALYSIS
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT DEVELOPEMENTS
11.2.6. DATA BRIDGE ANALYSIS
11.3. COLLAGEN MATRIX, INC.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT ANALYSIS
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPEMENTS
11.3.6. DATA BRIDGE ANALYSIS
11.4. INTEGRA LIFESCIENCES CORPORATION
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT ANALYSIS
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPEMENTS
11.4.6. DATA BRIDGE ANALYSIS
11.5. POLYGANICS B.V.
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT ANALYSIS
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT DEVELOPEMENTS
11.5.6. DATA BRIDGE ANALYSIS
11.6. STRYKER CORPORATION
11.6.1. COMPANY OVERVIEW
11.6.2. SWOT ANALYSIS
11.6.3. REVENUE ANALYSIS
11.6.4. PRODUCT PORTFOLIO
11.6.5. RECENT DEVELOPEMENTS
11.6.6. DATA BRIDGE ANALYSIS
11.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC.
11.7.1. COMPANY OVERVIEW
11.7.2. SWOT ANALYSIS
11.7.3. REVENUE ANALYSIS
11.7.4. PRODUCT PORTFOLIO
11.7.5. RECENT DEVELOPEMENTS
11.7.6. DATA BRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH

Other Report

Global Interventional Neurology Devices Market – Industry Trends and Forecast to 2024

Global Interventional Neurology Devices Market, By Product {(Aneurysm Coiling and Embolization Devices (Embolic Coils, Flow Diversion Devices, Liquid Embolic Devices), Angioplasty Devices (Carotid Artery Stents, Embolic Protection Systems), Micro Support Devices (Microguidewires, Microcatheters), Neurothrombectomy Devices (CLOT Retrieval Devices, Suction and Aspiration Devices, Snares)},Procedure (Embolization, Angioplasty,Neurothrombectomy, Others), End-User (Hospitals, Neurology Clinics, Ambulatory Care Centers, Others), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America) – Industry Trends and Forecast to 2024

Report Access: http://databridgemarketresearch.com/reports/global-interventional-neurology-devices-market/#utm_source=Openpr&utm_campaign=Shubham

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor:investors@databridgemarketresearch.com
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.